Article
What is new in the biology and treatment of pediatric rhabdomyosarcoma?
Current opinion in pediatrics - 1 Feb 2014
Hawkins Douglas S, Gupta Abha A, Rudzinski Erin R
Abstract excerpt
PURPOSE OF REVIEW: The purpose of this review is to highlight some of the advances in the way we think about rhabdomyosarcoma (RMS). Recent outcome and biological analyses have shifted the risk stratification and treatment paradigms for pediatric RMS. RECENT FINDINGS: The presence or absence of the FOXO1 translocation is one of the most important prognostic factors in RMS. Future clinical studies will incorporate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
